Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma

Selective targeting of anticancer drugs to the tumor site is beneficial in the pharmacotherapy of hepatocellular carcinoma (HCC). This study evaluated the prospective of galactosylated chitosan nanoparticles as a liver-specific carrier to improve the therapeutic efficacy of gemcitabine in HCC by tar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Molecules
Main Authors: Nair, Anroop B., Shah, Jigar, Al-Dhubiab, Bandar E., Patel, Snehal S., Morsy, Mohamed A., Patel, Vimal, Chavda, Vishal, Jacob, Shery, Sreeharsha, Nagaraja, Shinu, Pottathil, Attimarad, Mahesh, Venugopala, Katharigatta N.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943439/
https://ncbi.nlm.nih.gov/pubmed/31847085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24244566
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares